Press Releases

Participants Dosed on Adessia® in Germany in a Phase 1 Trial, a First for an Adalimumab Biosimilar Candidate Developed in Africa

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

MiGenTra Highlights How Biosimilars Are Transforming Healthcare in Africa at the Festival of Biologics
Media & Downloads
Press Contact

Sarah Wandrey
Corporate Communications
Phone: +49 (0) 30 3229 35 144
Email: press@probiogen.de